Erica Naomi Naka Matos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erica Naomi Naka Matos has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Alex Magno Coelho Horimoto
Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brasil
1 shared publication - Ana Luiza Garcia Cunha
Pediatric Rheumatology Department, Hospital Infantil Joao Paulo II, Belo Horizonte, Minas Gerais, Brazil
1 shared publication - Blanca Elena Rios Gomes Bica
Rheumatology Division, Federal University of Rio de Janeiro (UFRJ), Clementino Fraga Filho University Hospital, Rio de Janeiro, Brazil
1 shared publication - Carlos Nobre Rabelo Júnior
Hospital Geral de Fortaleza, Brazil
1 shared publication - Claudia Saad-Magalhaes
Pediatric Rheumatology Divison, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brazil
1 shared publication - Clovis Artur Silva
Instituto da Criança e do Adolescente, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 42, e2022184
Autoinflammatory diseases: a Latin American multicenter study according to age and sex
Objective: To evaluate autoinflammatory diseases (AID) according to age at diagnosis and sex, and response to therapy in a large population. Methods: This is a cross-sectional observational study of a Latin American registry using a designed web system for data storage, collected between 2015 and 2018. Any altered findings during follow-up were recorded. The forms were translated into Portuguese and Spanish, including demographic, clinical, laboratory, genetic and treatment characteristics. Results: We included 152 patients, 51.3% male and 75% Caucasian. The median age at disease onset was 2.1 years (0–15.6 years) and median age at diagnosis 6.9 years (0–21.9 years); 111 (73%) were children (0–9 years old), and 41 (27%) were adolescents and young adults (AYA) (10–21 years old). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA) occurred in 46/152 (30%), chronic non-bacterial osteomyelitis (CNO) in 32/152 (21%), and familial Mediterranean fever (FMF) in 24/152 (15.7%). PFAPA was significantly higher in young children than in AYA (38.7% vs. 7.3%, p<0.001), while CNO were lower (13.5% vs. 41.5%, p<0.001). The frequency of females was significantly higher in CNO (28.4% vs. 14.1%, p=0.031) and lower in FMF (8.1% vs. 23.1%, p=0.011). The most used drugs were glucocorticoids, non-steroidal anti-inflammatory drugs (NSAID), and colchicine. Glucocorticoids and colchicine treatment were used in all AID with good to moderate response. However, cryopyrin-associated periodic syndromes (CAPS) seemed unresponsive to glucocorticoids. NSAIDs and methotrexate were the main medications used to treat CNO. Conclusions: Differences among AID patients were observed in the LA population regarding sex and age at disease diagnosis.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 42, e2022184
Open AccessAutoinflammatory diseases: a Latin American multicenter study according to age and sex
Objective: To evaluate autoinflammatory diseases (AID) according to age at diagnosis and sex, and response to therapy in a large population. Methods: This is a cross-sectional observational study of a Latin American registry using a designed web system for data storage, collected between 2015 and 2018. Any altered findings during follow-up were recorded. The forms were translated into Portuguese and Spanish, including demographic, clinical, laboratory, genetic and treatment characteristics. Results: We included 152 patients, 51.3% male and 75% Caucasian. The median age at disease onset was 2.1 years (0–15.6 years) and median age at diagnosis 6.9 years (0–21.9 years); 111 (73%) were children (0–9 years old), and 41 (27%) were adolescents and young adults (AYA) (10–21 years old). Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA) occurred in 46/152 (30%), chronic non-bacterial osteomyelitis (CNO) in 32/152 (21%), and familial Mediterranean fever (FMF) in 24/152 (15.7%). PFAPA was significantly higher in young children than in AYA (38.7% vs. 7.3%, p<0.001), while CNO were lower (13.5% vs. 41.5%, p<0.001). The frequency of females was significantly higher in CNO (28.4% vs. 14.1%, p=0.031) and lower in FMF (8.1% vs. 23.1%, p=0.011). The most used drugs were glucocorticoids, non-steroidal anti-inflammatory drugs (NSAID), and colchicine. Glucocorticoids and colchicine treatment were used in all AID with good to moderate response. However, cryopyrin-associated periodic syndromes (CAPS) seemed unresponsive to glucocorticoids. NSAIDs and methotrexate were the main medications used to treat CNO. Conclusions: Differences among AID patients were observed in the LA population regarding sex and age at disease diagnosis.
- Open Access
- 1 March 2017
- Published by Elsevier in Revista Brasileira de Reumatologia (English Edition)
- Vol. 57 (2) , 107-114
Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil
- 1 March 2017
- Published by Elsevier in Revista Brasileira de Reumatologia (English Edition)
- Vol. 57 (2) , 107-114
Open AccessIncidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil